Allogeneic stem cell transplantation
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
... Conclusions: The data demonstrate in the largest retrospective cohort of non-cutaneous PTCL so far reported that alloSCT after RIC or MAC is an effective strategy, even in chemoresistant patients. Keywords: ...
12
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)
... Nonmyeloablative Transplantation. In: Soiffer RJ, editor. Hematopoietic Stem Cell ...given allogeneic hematopoietic cell transplanta- tion after nonmyeloablative ...to Allogeneic ...
7
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel
... after allogeneic hematopoietic stem cell transplantation ...blood allogeneic HSCT in malignant diseases to prevent severe acute and chronic ...
11
Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature
... Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treat- ment option in both adult and pediatric patients with malignant and non-malignant hemato- logical ...
10
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
... of allogeneic stem cell transplantation (alloSCT), a retrospective, registry-based comparison was performed, including 11,439 patients with de novo and 1325 with ...
10
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial
... We prospectively evaluated the safety and efficacy of a clofarabine, intravenous busulfan and antithymocyte glob- ulin-based reduced-toxicity conditioning (CloB2A2) regimen before allogeneic stem ...
7
Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases.
... SCT: Stem Cell Transplantation; Allo-SCT: Allogeneic Stem Cell Transplantation; BMT: Bone Marrow Transplant; PS: Propensity Score; IPW: Inverse Probability of treatment ...
11
Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT
... first allogeneic stem cell transplantation in all patients (95% confidence intervals were showed as dashed lines) (A) and in recipients of liver (solid line) and kidney (dashed line) grafts ...
10
Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome : a study from the French Society of Bone Marrow Transplantation and Cellular Therapy
... Marrow Transplantation. INTRODUCTION Allogeneic hematopoietic stem cell transplantation (allo- SCT) remains the only potentially curative therapeutic approach in patients with ...
9
Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
... Conclusions: The data demonstrate in the largest retrospective cohort of non-cutaneous PTCL so far reported that alloSCT after RIC or MAC is an effective strategy, even in chemoresistant patients. Keywords: ...
13
Allogeneic stem cell transplantation for chronic myelomonocytic leukemia : a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
... which allogeneic stem cell transplantation (allo-SCT) remains the only potentially curative ...Conclusions: Allogeneic stem cell transplantation is a valid ...
10
Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT
... (RIC) allogeneic stem cell transplantation into the mainstay of clinical management of older patients with acute lymphoblastic leukemia (ALL) more than a decade ago [1] represented a ...
8
Peripheral Blood Plasmacytoid Dendritic Cells at Day 100 Can Predict Outcome after Allogeneic Stem Cell Transplantation
... a b s t r a c t The rapidly increasing use of allogeneic stem cell transplantation (allo-SCT) emphasizes the need for iden- tifying variables predictive of its outcome. Plasmacytoid dendritic ...
7
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT.
... *MM and AN contributed equally to this work and share final co-authorship Relapse is the most frequent cause of failure after allogeneic stem cell transplantation (SCT) for acute myeloid or ...
6
Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
... autologous stem cell transplantation (ASCT) is a rare complica- tion with no curative ...option. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) may be ...
9
Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study
... received transplantation in CR2, a Karnofsky performance score of 90, diagnosed with acute myeloid leukemia, received transplantation from a matched unrelated donor (MUD) in 2011, and both recipient and ...
10
Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myeloma
... Gregoire et al. Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation Acta Clinica Belgica 2016 VOL . 71 NO . 6 429 effusion, concurrently with a new myeloma ...
4
Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma
... Renal cell carcinoma (RCC) is particularly sensitive to immune ...hematopoietic stem cell transplantation (HSCT), in particular the 14 bp insertion/deletion polymorphism in the 3 ′ ...
6
Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy
... Haematopoietic stem cell transplantation has been proposed as treatment for mitochondrial neurogastrointestinal encephalomyo- pathy, a rare fatal autosomal recessive disease due to TYMP mutations ...
12
Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.
... after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571 Donor lymphocyte infusion (DLI) has become standard therapy for relapse after ...
2